Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerGlycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsA systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancerClinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancerMolecular biomarkers for the detection of metastatic colorectal cancer cellsThe CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEAMIP-Based Sensors: Promising New Tools for Cancer Biomarker Determination.Simultaneous detection of nucleic acid and protein using gold nanoparticles and lateral flow deviceRadiation-induced tumor neoantigens: imaging and therapeutic implications.Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics dataIdentification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at RiskLimitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancerPreoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Newly Found Suspected Malignant Solitary Pulmonary Lesions in Patients Who Have Received Curative Treatment for Colorectal Cancer.Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigenCirculating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.International scientific communications in the field of colorectal tumour markersDirect and multiplex quantification of protein biomarkers in serum samples using an immuno-magnetic platform.Analysis of Isocitrate Dehydrogenase -2 (IDH-2) Activity in Human Serum as a Biomarker in Chemotherapy Patients of Breast Carcinoma: A Case-Control Study.A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity.Functional and genetic analysis of the colon cancer network.Biomarkers for colorectal cancerScreening for cancer with molecular markers: progress comes with potential problems.Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.Virtual gastrointestinal colonoscopy in combination with large bowel endoscopy: clinical applicationPROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORSUse of computed tomography in the management of colorectal cancer.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateLow-mass-ion discriminant equation: a new concept for colorectal cancer screeningPersistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients.Comparison between surgical outcomes of colorectal cancer in younger and elderly patients.Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv IntrabodyKinotypes: stable species- and individual-specific profiles of cellular kinase activity.
P2860
Q26746010-85367F38-29E2-4D0C-943F-131D361E8967Q26778227-60B483FD-431A-4123-887F-CF85A733EE6FQ26822552-C6E7BDC5-6349-4D36-9DC7-2EE1511A5554Q26849247-BEC4F28A-3D22-4C5F-9531-BFC3E263BFB6Q27002356-5B7C310F-DB2F-443A-ABEB-0EF7300DF88FQ27002450-DAFD5E61-DB8D-4B97-8DDC-6D8E2FF0202EQ28730117-ACBC0368-6946-463C-A5C3-9D5C59D894B4Q30356800-A0008455-1A8C-4ECA-A2F1-9590D3D088BBQ30434294-D4C560CD-13CE-4A7E-9A2B-3ED0379900B9Q30473856-ABDD9DC1-24DB-494E-89FC-6C2CF7C8197BQ30956148-4159C172-F29C-4805-B37C-043F5F932E39Q33237893-8306556C-F850-4AE2-8DC6-80F164B465B8Q33350682-A3489036-21CC-47DA-A062-26ABF153746EQ33450135-5DCE392F-1C46-4423-A096-79D1A9CA6A87Q33478415-0125DE8B-624F-4316-B32B-04371056D545Q33494754-4BE6DCCD-AA82-4449-84AB-CB71962FED8EQ33494978-80C19EF3-CCF2-4B32-B64D-BED60411C7D7Q33604839-79623141-D418-4E2B-80BC-7EB6E24F9D1EQ33626102-1A6A5370-686F-4C4C-A127-661D0D1816C4Q33648690-196C1FCC-8647-4C78-9A1E-077AAF46D57DQ33654179-3B7B644C-2D3C-4125-AD12-D40B479A9AB6Q33721159-8628A6FA-72C8-4F79-8BF4-DF216A6D9EA2Q33814117-6899D056-8B2F-4CE9-B651-67BEF7E1DB28Q33831823-14F9F208-BC34-4F37-A535-894A5012925FQ33952198-F7BC33DD-29EC-4C50-8080-C1AEB06BDCE2Q34153290-747089B3-25C8-45F1-8973-3E4E1433FF4CQ34205596-E65B9AAA-7185-42B5-9E16-C76D08D8CD04Q34267534-DD8C50CB-EC18-42EA-AADB-0FB81E804EC1Q34275247-DF99C7A8-D3BC-4C4B-8F0A-9426C4B070A1Q34326632-D1FB096F-B854-4A7D-8EB7-FF3AF2A8E9D4Q34343837-80521E0F-5084-44E9-9B68-E60DA2184B77Q34390519-51E930F6-6806-4E95-AD60-4F6F1514998BQ34441837-C62D788B-BC9A-4A57-B60F-5CE05B34D90FQ34521993-82C116A3-AE8D-4DAB-951C-C7699591232AQ34608433-CA9AE696-BA79-4056-9402-F2418352F364Q34689736-2E2D0BE2-562A-40A3-AD3D-E771698F4D90Q34727224-C568D1A7-96F7-423C-A77E-E8287DF32587Q34757504-A346C5CC-DE63-4B0A-843E-F30B953677ADQ35051275-E1D32664-6EE3-4EDC-A5E8-9527E75C31E4Q35061942-52A91742-6549-42A1-9102-12ED4C4F3230
P2860
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@ast
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@en
type
label
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@ast
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@en
prefLabel
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@ast
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@en
P1433
P1476
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?
@en
P2093
P304
P407
P577
2001-04-01T00:00:00Z